Semaglutide Linked to NAION Risk

• by Andrea Surnit

• May 11, 2026

ASRS President Reflects on a Year of Change

As his term comes to a close, Geoffrey G. Emerson, MD, PhD, FASRS, discusses scientific advances, physician advocacy, and the collaborative leadership behind ASRS.

• by Geoffrey G. Emerson, MD, PhD, FASRS

• July 15, 2026

• 3 min

Systemic factors associated with poor anatomical response to anti-VEGF therapy in patients with diabetic macular edema: evidence from a large clinical cohort

• by Xinru Jia, Yan Shi, Mengxiang He, Dongwei Yao, Chengfei Lin

• July 21, 2026

VesselMetaKAN: vessel-guided meta-learned interpretable classification for diabetic retinopathy grading

• by TianQi Yang, GuoYong Chen, Lu Liu

• July 16, 2026